Products & Services · Intangible asset impairments

osivelotor — Intangible asset impairments

Pfizer osivelotor — Intangible asset impairments remained flat by 0.0% to $205.00M in Q4 2025 compared to the prior quarter.

Analysis

StatementSegment
First reportedQ1 2025
Last reportedQ4 2025Feb 26, 2026
Rolls up toImpairment Charges
Metric ID: pfe_segment_osivelotor_intangible_asset_impairments

Historical Data

1 years
 FY'25
Value$820.00M

Frequently Asked Questions

What is Pfizer's osivelotor — intangible asset impairments?
Pfizer (PFE) reported osivelotor — intangible asset impairments of $205.00M in Q4 2025.